- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07670208
Physical Activity Promoting Active Aging
Physical Activity Promoting Active Aging: An Exploration of Intrinsic Mechanisms and Practical Pathways
This project aims to explore the effects and underlying mechanisms of physical activity in promoting active aging among older adults. The researchers conducted two rounds of progressive randomized controlled intervention trials to verify the effects and mechanisms of a multimodal physical activity intervention on active aging from two dimensions: intervention structure and participation mode.
In Study 1, with a 12-week intervention period, participants were randomly assigned to three groups: a Tai Chi exercise group, a multimodal exercise group, and a daily activity control group. By comparing between-group differences, the study evaluated the effects of different exercise modalities on physical function and subjective active aging.
In Study 2, also with a 12-week intervention period, participants were randomly assigned to two multimodal exercise groups differing in participation mode: an in-person group-based format versus an online individual format. This study examined the moderating effects of different participation modes on both objective and subjective active aging outcomes, while keeping the multimodal physical activity intervention content identical.
Visão geral do estudo
Status
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Department of Sports Science, College of Education, Zhejiang University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Aged 60 years or above;
Capable of engaging in regular physical activities and comprehending basic testing procedures and instructions.
Exclusion Criteria:
- Severe cardiac, pulmonary, or musculoskeletal disorders;
History of neurological or psychiatric conditions that may impair cognitive function (e.g., stroke, Parkinson's disease, Alzheimer's disease, major depressive disorder, etc.);
Missing three or more scheduled intervention sessions during the study period, or requesting discontinuation of participation.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Grupo de controle
|
|
|
Experimental: Grupo de exercícios multicomponentes
|
Tai Chi, Baduanjin, strength, balance, and flexibility exercises
|
|
Experimental: Mind-body exercise group
|
Tai Chi, Yoga, and Baduanjin
|
|
Experimental: Online-based multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered via live online streaming and video watching)
|
|
Experimental: In-person multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered in an in-person group format)
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Active aging
Prazo: week0, week6, week12
|
It was measured using the Active Aging Questionnaire.
|
week0, week6, week12
|
|
General self-efficacy
Prazo: week0, week6, week12
|
It was measured using the General Self-Efficacy Scale.
|
week0, week6, week12
|
|
Cognitive function
Prazo: week0, week6, week12
|
Cognitive function was measured using the cognitive subscale of the LEIPAD questionnaire
|
week0, week6, week12
|
|
Cognitive function assessed by the Montreal Cognitive Assessment (MOCA)
Prazo: week0, week6, week12
|
Cognitive function was measured using the Montreal Cognitive Assessment (MOCA).
|
week0, week6, week12
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Height
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
Weight
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
Body fat percentage
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
Vital capacity test
Prazo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
2-minute high-knee marching in place
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
Handgrip strength
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
Sit and reach test
Prazo: week0, week6, week12
|
week0, week6, week12
|
|
|
30-second chair stand test
Prazo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
One-legged stance with eyes closed tesr
Prazo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
Choice reaction time
Prazo: week0, week6, week12
|
week0, week6, week12
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- ZJU-SSEC/2025/No.6
- 23NDJC001Z (Número de outro subsídio/financiamento: Key Program of Philosophy and Social Sciences Planning of Zhejiang Province)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .